Literature DB >> 26083268

Usefulness of several biomarkers in the management of septic patients: C-reactive protein, procalcitonin, presepsin and mid-regional pro-adrenomedullin.

Alfredo Enguix-Armada, Rocío Escobar-Conesa, Angela García-De La Torre, María Victoria De La Torre-Prados.   

Abstract

BACKGROUND: Our objective is to analyze whether the combination of C-reactive protein (CRP), procalcitonin (PCT), presepsin or SCD14-ST and mid-regional pro-adrenomedullin (MR-proADM) measured in the first 24 h from ICU admission allowing a better management of septic patients (diagnostic and prognostic) both in severe sepsis (SS) and septic shock (SSh).
METHODS: Cohort study of 388 patients admitted in the ICU during 12 months of whom 142 were controls. Biomarkers were measured through immunoluminometric assays in samples of serum or plasma within the first 24 h after admission. Data were evaluated with non-parametric statistics bivariant, ROC curve analysis for diagnostic evaluation and multivariate analyses for survival analysis.
RESULTS: In the analyzed cohort, 61.8% of patients were males, mean age: 63 years range (18-90) and 67.8% in controls mean age: 63 years, range (39-91). PCT showed the highest area under the curve (AUC) (0.989) as compared with the rest of biomarkers (p<0.01). PCT also enabled the difference between Gram-positive or Gram-negative bacteria to be determined. The AUCs for CRP (0.922) and presepsin (0.948) showed a similar diagnostic value. In cases of SSh, the AUC of presepsin experienced a noticeable increase (p<0.0001). MR-proADM showed a better prognostic value (p=0.00022) particularly in cases of SSh (p=0.00001) increasing along with the APACHE-II score.
CONCLUSIONS: PCT, MR-proADM and presepsin are complementary markers that could be of great help in the management of septic patients when they are measured in the first 24 h after ICU admission.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26083268     DOI: 10.1515/cclm-2015-0243

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  19 in total

Review 1.  Long Noncoding RNA: Regulatory Mechanisms and Therapeutic Potential in Sepsis.

Authors:  Wei Wang; Ni Yang; Ri Wen; Chun-Feng Liu; Tie-Ning Zhang
Journal:  Front Cell Infect Microbiol       Date:  2021-05-12       Impact factor: 5.293

2.  Presepsin teardown - pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosis.

Authors:  Maria Papp; Tamas Tornai; Zsuzsanna Vitalis; Istvan Tornai; David Tornai; Tamas Dinya; Andrea Sumegi; Peter Antal-Szalmas
Journal:  World J Gastroenterol       Date:  2016-11-07       Impact factor: 5.742

Review 3.  Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy.

Authors:  Ashitha L Vijayan; Shilpa Ravindran; R Saikant; S Lakshmi; R Kartik; Manoj G
Journal:  J Intensive Care       Date:  2017-08-03

4.  The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis - a secondary analysis of a large randomised controlled trial.

Authors:  Gunnar Elke; Frank Bloos; Darius Cameron Wilson; Frank Martin Brunkhorst; Josef Briegel; Konrad Reinhart; Markus Loeffler; Stefan Kluge; Axel Nierhaus; Ulrich Jaschinski; Onnen Moerer; Andreas Weyland; Patrick Meybohm
Journal:  Crit Care       Date:  2018-03-21       Impact factor: 9.097

Review 5.  Biomarkers of sepsis: time for a reappraisal.

Authors:  Charalampos Pierrakos; Dimitrios Velissaris; Max Bisdorff; John C Marshall; Jean-Louis Vincent
Journal:  Crit Care       Date:  2020-06-05       Impact factor: 9.097

Review 6.  Mid-Regional Pro-Adrenomedullin (MR-proADM) as a Biomarker for Sepsis and Septic Shock: Narrative Review.

Authors:  Uğur Önal; Francisco Valenzuela-Sánchez; Kalwaje Eshwara Vandana; Jordi Rello
Journal:  Healthcare (Basel)       Date:  2018-09-03

7.  An Evaluation of Serum Procalcitonin and C-Reactive Protein Levels as Diagnostic and Prognostic Biomarkers of Severe Sepsis.

Authors:  Janos Szederjesi; Emoke Almasy; Alexandra Lazar; Adina Huțanu; Iudita Badea; Anca Georgescu
Journal:  J Crit Care Med (Targu Mures)       Date:  2015-11-10

Review 8.  Presepsin as a Diagnostic and Prognostic Biomarker in Sepsis.

Authors:  Dimitrios Velissaris; Nicholas Zareifopoulos; Vasileios Karamouzos; Evangelos Karanikolas; Charalampos Pierrakos; Ioanna Koniari; Menelaos Karanikolas
Journal:  Cureus       Date:  2021-05-13

9.  Diagnostic and prognostic value of soluble CD14 subtype (Presepsin) for sepsis and community-acquired pneumonia in ICU patients.

Authors:  Kada Klouche; Jean Paul Cristol; Julie Devin; Vincent Gilles; Nils Kuster; Romaric Larcher; Laurent Amigues; Philippe Corne; Olivier Jonquet; Anne Marie Dupuy
Journal:  Ann Intensive Care       Date:  2016-07-07       Impact factor: 6.925

10.  Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in Sepsis after Major Abdominal Surgery.

Authors:  Suzana Bojic; Jelena Kotur-Stevuljevic; Aleksandra Aleksic; Jasna Gacic; Lidija Memon; Sanja Simic-Ogrizovic
Journal:  Dis Markers       Date:  2018-05-16       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.